Craft

OnCusp Therapeutics

Total Funding

$125 M

OnCusp Therapeutics Summary

Company Summary

Overview
OnCusp Therapeutics is a biopharmaceutical company that specializes in cancer treatment solutions. It focuses on developing bispecific antibodies, antibody-drug conjugates, and small-molecule therapies for the treatment of cancer.
Type
Private
Status
Active
Founded
2021
HQ
New York, NY, US | view all locations
Website
https://www.oncusptx.com/
Cybersecurity rating
Sectors

Key People

  • Bing Yuan

    Bing Yuan, Co-Founder, Chairman, and CEO

  • Eric Slosberg

    Eric Slosberg, Co-Founder, Chief Development Officer, and Head of Research and Development

  • Andy Fu

    Andy Fu, Co-Founder, Chief Business Officer

LocationsView all

3 locations detected

  • New York, NY HQ

    United States

    433 Broadway

  • Shanghai, Shang Hai Shi

    China

    989 ChangLe Road

  • Shanghai, Shang Hai Shi

    China

    Suite 802, No. 1576, West Nanjing Rd

Footer menu